Science News
•87% Informative
It Cleveland Clinic risk of dying A. Michael Lincoff — over the roughly 40 months patients participated in the study.
In the United States alone, more than 6 million obese or overweight people have cardiovascular dis Wegovy ut not diabetes.
Participants on semaglutide were sligh 20 percent ik Lincoff drop out o November 11 than those taking the placebo.
That difference seemed to the roughly 40 months ’s gastrointestinal side effects, which include Lincoff diarrhea and vomiting.
The number of serious issues that occurred, like cancer or infection, was slightly lower in the group. n’t 2 an class="summaryFeed_highLightText__NxlGi">Powell-Wile obese an> first >Hispanic African-American the United States Tiffany Powell-Wiley ightText__NxlGi">Lincoff the National Heart _h Lung ightT Blood Institute perc Bethesda n> Md. span the United States ed_highL more than 6 million obese nt Powell-Wiley t Powell-Wiley an> SELECT Lincoff Novo Nordisk’s Powell-Wiley n Harvard Medical School and Brigham and Women’s Hospital Caroline Apovian one first 29/23 SN Semaglutide s="summaryFeed_highLightText__NxlGi">August November 8 Te the U.S. Food and Drug Administration class="summaryFeed_highLightText__NxlGi">Khera Zepbound NxlGi">obese
VR Score
91
Informative language
93
Neutral language
62
Article tone
semi-formal
Language
English
Language complexity
55
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links